Seniors'Health Paths " PAERPA ", (PAERPA)
Seniors'Health Paths " PAERPA ", a Support Being Made Available to General Practionners for Assistance in the Management of Elderly Persons at Risk of Losing Their Independence. Review of the Implementation of the Arrangement on the Est-héraultais Territory.
•Background: PAERPA experimentation implemented in the East-Herault region since September 2017 aims to identify fragility and prevent the risk of loss of autonomy in elderly persons older than 60 years by facilitating coordination between Professionals taking care of the patient with the personalized health plan " PPS". The main objective of this study was to evaluate the implementation of this device through the achievement or not of the objectives set by the PPS.
•Methods: Descriptive cohort study with retrospective inclusion and prospective follow-up from the East Herault CTA database. All patients over 60 years old living at home and having a PPS written between September 2017 and April 2018 were included. PPS monitoring for 1 year. Description of this population then analysis of PPS.
•Discussion: Our study aims to evaluate the implementation of the device to identify ways to improve the device for the management of subjects at risk of loss of autonomy.
研究概览
地位
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Montpellier、法国、34295
- UHMontpellier
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
An individual must fulfill all of the following criteria in order to be eligible for study enrollment:
- Aged of 60 years and more
- individual health care plan was prepared
- living in the Est-Héraultais territory
Exclusion Criteria:
- Hospitalized patients
- Patients who declined to have an individual heath care planPsychosis
学习计划
研究是如何设计的？
设计细节
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Estimating goals set by the PPS (personalized health plan)
大体时间：6 and 12 month follow-up
|
achievement of objectives established in the individual health care plan after 6 and 12 month follow-up
|
6 and 12 month follow-up
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
correlation between unwillingness and cognitive disorder
大体时间：1 day
|
correlation between unwillingness and cognitive disorder
|
1 day
|
|
Correlation between unwillingness and numbers of established goals
大体时间：1 day
|
Correlation between unwillingness and numbers of established goals
|
1 day
|
|
Correlation between unwillingness and locomotors goals
大体时间：1 day
|
Correlation between unwillingness and locomotors goals
|
1 day
|
合作者和调查者
调查人员
- 首席研究员：Chokri Boubakri, MD、University Hospitals of Montpellier
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- RECHMPL19_0513
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
Loss of Autonomy的临床试验
-
Swansea University完全的
-
Scripps Translational Science Institute完全的